Lannett Company

With three facilities in Philadelphia, PA, Lannett Company, Inc. manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Our portfolio consists of numerous products across a wide range of therapeutic areas. We believe that our ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate ourselves into certain specialty markets and achieve economies in production are all critical for our success in the generic pharmaceutical industry in which we operate.

Having cultivated strong and dependable customer relationships by maintaining adequate inventory levels and demonstrating a responsive order filling system, we take pride in our ability to satisfy our customer’s needs. Our dedicated employees strive to position Lannett as an industry leader that is focused on quality and integrity, as well as giving back to the community we serve. Lannett has a history of supporting schools, hospitals, veterans and their families, institutions, rehabilitation centers, cancer research, as well as the local fire and police departments.
Philadelphia, US
Size (employees)
1,149 (est)
Lannett Company was founded in 1942 and is headquartered in Philadelphia, US

Lannett Company Office Locations

Lannett Company has offices in Philadelphia, Charlotte, Carmel-by-the-Sea, Dallas and in 13 other locations
Philadelphia, US (HQ)
13200 Townsend Rd

Lannett Company Data and Metrics

Lannett Company Financial Metrics

Lannett Company's revenue was reported to be $542.5 m in FY, 2016 which is a 33% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

542.5 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

305.1 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

44.9 m

EBIT (FY, 2016)

130.8 m

Market capitalization (26-May-2017)

746.5 m

Closing share price (26-May-2017)


Cash (31-Dec-2016)

224.8 m


699.9 m
Lannett Company's current market capitalization is $746.5 m.
Numbers are in $, USDFY, 2014FY, 2015FY, 2016


273.8 m406.8 m542.5 m

Revenue growth, %


Cost of goods sold

99.3 m100.5 m237.4 m

Gross profit

174.5 m306.4 m305.1 m

Gross profit Margin, %


Operating expense total

66.3 m79.9 m155.7 m


88.1 m226.5 m130.8 m

EBIT margin, %


Interest expense

130 k207 k65.9 m

Pre tax profit

90 m227.4 m62.2 m

Income tax expense

32.9 m77.4 m17.3 m

Net Income

57.2 m150 m44.9 m
Numbers are in $, USDFY, 2014FY, 2015FY, 2016


105.6 m200.3 m224.8 m

Accounts Receivable

61.3 m91.1 m211.7 m


44.8 m46.2 m114.9 m

Current Assets

265.5 m370.5 m612.8 m


61.7 m94.6 m216.6 m

Total Assets

342.8 m508.8 m1.8 b

Accounts Payable

21 m19.2 m34.7 m

Total Debt

129 k135 k178.2 m

Current Liabilities

47 m44.1 m306.7 m

Common Stock

36 k37 k37 k

Additional Paid-in Capital

216.8 m236.2 m283.3 m

Retained Earnings

83.7 m233.6 m278.4 m

Total Equity

294.8 m463.8 m554.5 m

Debt to Equity Ratio

0 x0 x0.3 x

Debt to Assets Ratio

0 x0 x0.1 x

Financial Leverage

1.2 x1.1 x3.2 x
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Net Income

57.2 m150 m44.9 m

Depreciation and Amortization

6 m5.6 m18.6 m

Accounts Receivable

(35 m)(25 m)15.1 m


(12 m)1.4 m15.3 m

Accounts Payable

(1.7 m)(2.5 m)(3.7 m)

Cash From Operating Activities

45.1 m128.5 m135.3 m

Purchases of PP&E

(107.4 m)(95.7 m)(81.1 m)

Cash From Investing Activities

(56.4 m)(45.8 m)(959.1 m)

Long-term Borrowings

(5.4 m)(129 k)(295 m)

Cash From Financing Activities

74.2 m12.3 m848.2 m

Interest Paid

130 k206 k52.9 m

Income Taxes Paid

34.3 m75.6 m35.1 m
Numbers are in $, USDY, 2016


5.4 x


5.2 x


1.1 m


0.3 x


0.1 x

Financial Leverage

3.2 x

Lannett Company Market Value History

Lannett Company Job Categories

Lannett Company News and Updates

Lannett Company Company Life and Culture

You may also be interested in